CD8A and neoplasm: RAPA@BSA-PCN@HA can effectively inhibit tumor growth in 4T1 tumor models; DAMPs release (CRT, HMGB1 ↑); T cell infiltration (CD4+ T cells, CD8+ T cells ↑);